Detalhe da pesquisa
1.
Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19.
Medicina (Kaunas)
; 58(3)2022 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35334625
2.
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stentã- 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
Circ J
; 83(7): 1489-1497, 2019 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155604
3.
Prognostic Implication of Platelet Reactivity According to Procedural Complexity After PCI: Subanalysis of PTRG-DES Consortium.
JACC Asia
; 4(3): 185-198, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463677
4.
Left bundle branch area pacing in mildly reduced heart failure: A systematic literature review and meta-analysis.
Clin Cardiol
; 46(7): 713-720, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144691
5.
A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
J Am Coll Cardiol
; 63(25 Pt A): 2805-16, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814486
6.
Rupture and spontaneous sealing of a coronary aneurysm after deployment of drug-eluting stent.
Korean Circ J
; 42(8): 558-61, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22977452
7.
Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study.
Circ Cardiovasc Interv
; 5(3): 365-71, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693347